Merck seeks FDA emergency use authorization for antiviral COVID-19 treatment molnupiravir

Pharmaceutical giant Merck has applied for Emergency Use Authorization for its promising antiviral COVID-19 treatment.

If the FDA grants approval, it would be the first pill in the US to treat the coronavirus disease.